Life Science REIT has launched a strategic review that could see it sold or wound down, with several buyers already showing interest in buying the company.
The company said in a stock exchange announcement that the review, led by Panmure
Life Science REIT has launched a strategic review that could see it sold or wound down, with several buyers already showing interest in buying the company.
The company said in a stock exchange announcement that the review, led by Panmure
Our mission is to support you in finding and assessing investment and development opportunities faster.
Help us do just that by taking part in an exclusive product testing session.
Sign up nowKind regards,
The EG team